We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Quantum Dot Technology Increases Efficacy of Antibiotics

By LabMedica International staff writers
Posted on 18 Oct 2017
A team of molecular microbiologists used quantum dot technology to increase the efficacy of antibiotics to the point where they became capable of killing strains of "antibiotic-resistant" organisms.

Quantum dots are minute semiconductor particles, only several nanometers in size, so small that their optical and electronic properties differ from those of larger particles. More...
Many types of quantum dots will emit light of specific frequencies if electricity or light is applied to them, and these frequencies can be precisely tuned by changing the dots' size, shape, and material, giving rise to many applications.

Interest in the potential use of quantum dots to augment antibiotic potency comes from growing concern in the increasing number of multidrug-resistant (MDR) bacteria, an increase that has been exacerbated by the lack of new antibiotics. To treat already pervasive MDR infections, new classes of antibiotics or antibiotic adjuvants are needed. Reactive oxygen species (ROS) have been shown to play a role during antibacterial action; however, it is not yet understood whether ROS contribute directly to or are an outcome of bacterial lethality caused by antibiotics.

In this regard, investigators at the University of Colorado (Boulder, USA) reported in the October 4, 2017, online edition of the journal Science Advances that a light-activated nanoparticle, designed to produce a tunable flux of specific ROS, superoxide, potentiated the activity of antibiotics in clinical MDR isolates of Escherichia coli, Salmonella enterica, and Klebsiella pneumoniae. Despite the high degree of antibiotic resistance in these isolates, the investigators observed a synergistic interaction between both bactericidal and bacteriostatic antibiotics with varied mechanisms of action and the superoxide-producing nanoparticles in more than 75% of combinations. As a result of this potentiation, the dots reduced the effective antibiotic resistance of the clinical isolate infections by a factor of 1,000 without producing adverse side effects.

In addition, the investigators showed that superoxide-generating nanoparticles in combination with the antibiotic ciprofloxacin reduced bacterial load in epithelial cells infected with S. enterica serovar Typhimurium and increased the survival of the roundworm Caenorhabditis elegans upon infection with S. enterica serovar Enteriditis, compared to antibiotic alone.

“We are thinking more like the bug,” said senior author Dr. Anushree Chatterjee, assistant professor of chemical and biological engineering at the University of California. “This is a novel strategy that plays against the infection’s normal strength and catalyzes the antibiotic instead. Overall, the most important advantage of the quantum dot technology is that it offers clinicians an adaptable multifaceted approach to fighting infections that are already straining the limits of current treatments. Disease works much faster than we do. Medicine needs to evolve as well.”

Related Links:
University of Colorado


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated PCR Setup
ESTREAM
New
Candida Glabrata Test
ELIchrom Glabrata
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.